World-leading contract research organization Sygnature Discovery has announced a major new hire to its leadership team, with the appointment of Dr David Witty as Chief Scientific Officer (CSO) to ensure its integrated drug discovery capabilities remain at the cutting edge of the industry.
David will be responsible for ensuring Sygnature Discovery remains globally recognised for the quality of its scientific operations and is able to attract the top scientific talent in the industry.